Report for Since M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment - Adnet_2020_Pharmaceutics_12_
Author(s) : Adnet T , Groo AC , Picard C , Davis A , Corvaisier S , Since M , Bounoure F , Rochais C , Pluart LL , Dallemagne P , Malzert-Freon A
Ref : Pharmaceutics , 12 : , 2020
Abstract : Adnet_2020_Pharmaceutics_12_
ESTHER : Adnet_2020_Pharmaceutics_12_
PubMedSearch : Adnet_2020_Pharmaceutics_12_
PubMedID: 32168767

Title : Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT(6) receptor antagonist with therapeutic interest in Alzheimer's disease - Toublet_2020_Eur.J.Med.Chem_210_113059
Author(s) : Toublet FX , Lalut J , Hatat B , Lecoutey C , Davis A , Since M , Corvaisier S , Freret T , Sopkova-de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 210 :113059 , 2020
Abstract : Toublet_2020_Eur.J.Med.Chem_210_113059
ESTHER : Toublet_2020_Eur.J.Med.Chem_210_113059
PubMedSearch : Toublet_2020_Eur.J.Med.Chem_210_113059
PubMedID: 33310288

Title : Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease - Toublet_2019_Molecules_24_
Author(s) : Toublet FX , Lecoutey C , Lalut J , Hatat B , Davis A , Since M , Corvaisier S , Freret T , Sopkova de Oliveira Santos J , Claeysen S , Boulouard M , Dallemagne P , Rochais C
Ref : Molecules , 24 : , 2019
Abstract : Toublet_2019_Molecules_24_
ESTHER : Toublet_2019_Molecules_24_
PubMedSearch : Toublet_2019_Molecules_24_
PubMedID: 31370232

Title : Benzylphenylpyrrolizinones with Anti-amyloid and Radical Scavenging Effects, Potentially Useful in Alzheimer's Disease Treatment - Jourdan_2017_ChemMedChem_12_913
Author(s) : Jourdan JP , Since M , El Kihel L , Lecoutey C , Corvaisier S , Legay R , Sopkova-de Oliveira Santos J , Cresteil T , Malzert-Freon A , Rochais C , Dallemagne P
Ref : ChemMedChem , 12 :913 , 2017
Abstract : Jourdan_2017_ChemMedChem_12_913
ESTHER : Jourdan_2017_ChemMedChem_12_913
PubMedSearch : Jourdan_2017_ChemMedChem_12_913
PubMedID: 28342294

Title : Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment - Jourdan_2016_Eur.J.Med.Chem_114_365
Author(s) : Jourdan JP , Since M , El Kihel L , Lecoutey C , Corvaisier S , Legay R , Sopkova-de Oliveira Santos J , Cresteil T , Malzert-Freon A , Rochais C , Dallemagne P
Ref : Eur Journal of Medicinal Chemistry , 114 :365 , 2016
Abstract : Jourdan_2016_Eur.J.Med.Chem_114_365
ESTHER : Jourdan_2016_Eur.J.Med.Chem_114_365
PubMedSearch : Jourdan_2016_Eur.J.Med.Chem_114_365
PubMedID: 27046230

Title : Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography - Lalut_2016_Eur.J.Med.Chem_116_90
Author(s) : Lalut J , Tournier BB , Cailly T , Lecoutey C , Corvaisier S , Davis A , Ballandonne C , Since M , Millet P , Fabis F , Dallemagne P , Rochais C
Ref : Eur Journal of Medicinal Chemistry , 116 :90 , 2016
Abstract : Lalut_2016_Eur.J.Med.Chem_116_90
ESTHER : Lalut_2016_Eur.J.Med.Chem_116_90
PubMedSearch : Lalut_2016_Eur.J.Med.Chem_116_90
PubMedID: 27060761

Title : Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment - Lecoutey_2014_Proc.Natl.Acad.Sci.U.S.A_111_E3825
Author(s) : Lecoutey C , Hedou D , Freret T , Giannoni P , Gaven F , Since M , Bouet V , Ballandonne C , Corvaisier S , Malzert Freon A , Mignani S , Cresteil T , Boulouard M , Claeysen S , Rochais C , Dallemagne P
Ref : Proc Natl Acad Sci U S A , 111 :E3825 , 2014
Abstract : Lecoutey_2014_Proc.Natl.Acad.Sci.U.S.A_111_E3825
ESTHER : Lecoutey_2014_Proc.Natl.Acad.Sci.U.S.A_111_E3825
PubMedSearch : Lecoutey_2014_Proc.Natl.Acad.Sci.U.S.A_111_E3825
PubMedID: 25157130